Paradigm Health Announces Oncology and Healthcare Expert Dr. Karen E. Knudsen Appointed to Board of Directors and Launch of New AI-Driven Solution for Clinical Trial Data Collection and Management

Paradigm Health, which is rebuilding the clinical research ecosystem, today announced the appointment of Karen E. Knudsen, MBA, PhD, to its Board of Directors, alongside the upcoming launch of its eSource clinical trial data application.

Dr. Knudsen is a globally recognized cancer scientist and executive leader who joins Paradigm Health's board following a successful term as Chief Executive Officer of the American Cancer Society (ACS) and its advocacy affiliate, ACS Cancer Action Network. She brings extensive expertise around the challenges and opportunities in clinical research to this Board appointment.

"Seeing eSource Casebook in action was a lightning bolt moment," said Knudsen. "Today's infrastructure forces provider research teams into an exhausting cycle of finding and documenting patient information in their EMR, only to re-enter nearly identical details into trial-specific electronic data capture systems. This redundant, manual process is not only time-consuming but also incredibly resource-draining. It's followed by costly, labor-intensive audits to ensure data accuracy. From my experience, these inefficiencies place an overwhelming burden on providers, stretching their resources thin, creating friction between stakeholders, and ultimately preventing them from considering new research opportunities. In past roles, I would have loved access to a tool that alleviates this pressure, bringing interoperability and data accuracy while saving time and reducing costs. eSource Casebook does just that."